Connect with Us at
BIO 2026
Everest is Your Data-First,
Full-Service CRO
Let's connect at BIO 2026 and discuss how Everest's data-first approach can help you make faster, smarter development decisions with confidence.
Complete the form to schedule a meeting with our team in San Diego.
Here's why sponsors repeatedly choose Everest:
Your trial data comes first—always.
As a biometrics provider turned full-service CRO, we bring a deep, data-first mindset to every study. That means cleaner data, fewer surprises, and faster decision-making.
Operational excellence you can feel.
We deliver clinical trials with a level of rigor, responsiveness, and reliability that sponsors consistently say is rare in our industry.
Customer service that stands out.
Our teams act as true extensions of yours—proactive, highly engaged, and committed to solving problems before they become barriers.
Flexibility at our core.
We can deliver support exactly how you need it: Project-based or turn-key (full-service or selected services), FSP, unit-based or time and materials.
About Everest Clinical Research
Our story began more than 20 years ago as a dedicated biometrics service provider. Over the last decade, we’ve evolved into a full-service CRO—bringing the same data-driven discipline, scientific rigor, and precision to every part of clinical trial delivery.
Today, we’re a global organization with offices across North America, Europe, and Asia, and a team of more than 700 experts. We’re small enough to stay nimble, responsive, and personalized—yet large enough to deliver the global experience and operational strength required for successful clinical trials.
Your BIO 2026 On-site Team
Book Your Meeting Now
News from Everest Clinical Research
Can AI Eliminate “Dead Time” in Drug Development?
FDA’s Emerging Vision for Real-Time Clinical Trials
Over the last 10-15 years, the amount of time spent between clinical trials, including administrative closeout and key decision points, has significantly increased. A new initiative by FDA aims to reduce “dead time” between clinical trial phases.
Solving Operational Complexity in ADC Oncology Trials: From Design to Execution
Many sponsors encounter a consistent challenge: ADC clinical trials introduce a level of operational complexity that goes well beyond traditional oncology trials.
How Bayesian Dose-Finding Designs Can Accelerate Early-Phase Oncology Clinical Research
Historically used more frequently in exploratory analyses, Bayesian approaches are now increasingly recognized as viable frameworks for primary analysis in drug and biologic development—when appropriately designed and justified.
Everest Strengthens Global Biometrics Capabilities with Expansion in Poland
TORONTO – November 24, 2025 – Everest Clinical Research— a data-driven and quality-focused global CRO — is…
Everest Enhances Regulatory Strategy and Capabilities with the Appointment of Kevin Barber as Senior Vice President of Global Regulatory Strategy and Submissions
TORONTO — July 30, 2025 — Everest Clinical Research, a quality and data-driven global CRO, announces the appointment…
Everest Clinical Research Enables Faster and Higher Quality Data Insights for Trial Sponsors with Medidata Clinical Data Studio
TORONTO –June 5, 2025 – Medidata, a Dassault Systèmes brand, today announced that Everest Clinical Research, a global full-service
Everest Clinical Research Announces Key Leadership Appointments to Drive Continued Growth
TORONTO – February 13, 2025 – Everest Clinical Research Corporation (Everest), a global full-service Contract Research Organization (CRO),…